Rolando Saenz, MD
Colon & Rectal Surgery · San Antonio, TXNPI 1316962723
Payments from drug & device makers
What this record shows
This record is dominated by education: $10,000 of the $15,421 with a category attached, or 64.8%. Intuitive Surgical accounts for 92.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $8,879 and has fallen 81.3% since, to $1,663 in 2025.
Across 84 payments — averaging $183.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$14K
- KCI USA, Inc.$263
- Davol Inc.$186
- Sanara Medtech Inc.$157
- TELA Bio, Inc.$149
- Conmed Corporation$116
- plus $352 from 10 others
What the payments were for
- Travel & lodging$2,76118%
- Food & beverage$2,64617%
- Education$10,00065%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 52 | $14,197 |
| KCI USA, Inc. | 3 | $263 |
| Davol Inc. | 4 | $186 |
| Sanara Medtech Inc. | 1 | $157 |
| TELA Bio, Inc. | 3 | $149 |
| Conmed Corporation | 2 | $116 |
| TEI Biosciences Inc | 4 | $94 |
| Integra Lifesciences Corporation | 5 | $88 |
| Shire North American Group Inc | 2 | $45 |
| Biotissue Holdings Inc. | 2 | $32 |
| Kerecis Limited | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Smith+Nephew | 1 | $15 |
| Acera Surgical, Inc. | 1 | $12 |
| Bard Access Systems, Inc. | 1 | $12 |
| Cook Medical LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$10,267
- DAVINCI XI$3,000
- CellerateRx$157
- Phasix Mesh$133
- Ovitex$121
How this compares
$15,421 in reported general payments places this provider in the 75th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 21 | $13,143 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 47 | $2,788 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 16 | $2,559 |
| Dicyclomine Hcl | 48 | $724 |
| Pantoprazole Sodium | 37 | $488 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $307 |
| Omeprazole | 15 | $287 |
| Mupirocin | 19 | $155 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $90 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in San Antonio
- Christopher de JesusSan Antonio$201K
- William LewisSan Antonio$85K
- Jaime MayoralSan Antonio$84K
- Michael KellerSan Antonio$50K
- Maria Martinez UgarteSan Antonio$47K
- James PrietoSan Antonio$16K
- Mario AlcantaraSan Antonio$14K
- Thiru LakshmanAustin$756K
- Diego Marines CopadoHouston$462K
- Bidhan DasSugar Land$350K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.